Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
Clinical trial NCT07420816 · RECRUITING
Trial details
- NCT number
- NCT07420816
- Sponsor
- Apsen Farmaceutica S.A.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-05
- Primary completion
- 2027-12-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.